Physician profile
Christopher Robert Vitale
NPI 1679884068
$6,864.88
in general payments reported to CMS, 2019-2025
25 companies · $1,055 in 2025
The $1,055 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,058 · 2020: $604 · 2021: $186 · 2022: $347 · 2023: $955 · 2024: $659 · 2025: $1,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,299 · Travel and Lodging: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,299.39 |
| Travel and Lodging | $369.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,763.44 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Simpliciti |
| Depuy Synthes Sales INC. | $993.76 | 2019-2025 | Actis, Na, Tfn-Advance |
| Smith+Nephew, INC. | $347.42 | 2019-2022 | |
| Si-Bone, INC. | $281.65 | 2020-2025 | |
| Kuros Biosciences USA, INC | $154.49 | 2025 | Magnetos |
| Axogen | $138.43 | 2019 | |
| Davol INC. | $126.63 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $124.74 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $111.25 | 2025 | Iovera |
| Acera Surgical, INC. | $110.44 | 2025 | Restrata Wound Matrix |
| Heron Therapeutics, INC. | $107.10 | 2022 | |
| Orthofix Medical, INC. | $101.72 | 2025 | Physio-Stim |
| Pinnacle, INC | $94.42 | 2023 | |
| Zimmer Biomet Holdings, INC. | $94.34 | 2019 | |
| Kerecis Limited | $57.81 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $48.27 | 2025 | Si-Lok |
| Organogenesis INC. | $33.36 | 2025 | Puraply Wound Matrix |
| Pacira Therapeutics, INC. | $32.17 | 2020 | |
| Nevro Corp. | $27.45 | 2023 | Senza |
| Convatec INC. | $25.71 | 2023 | |
| Bioventus LLC | $25.55 | 2019-2021 | |
| Integra Lifesciences Corporation | $18.03 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Providence Medical Technology, INC. | $18.02 | 2023 | |
| Abbott Laboratories | $16.48 | 2023 | Proclaim |
| Boston Scientific Corporation | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Vitale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.